In this session, we’ll go through various examples of pharma projects to tell an integrated story of the key challenges and solutions available to big pharma brands.
Pharmaceutical and Life Science companies have caught the omnichannel bug. Around the world, they are quickly forming teams and investing millions.
Often, these initiatives are led by highly competent staff who have years of pharma experience, but they’re suddenly being asked to develop and execute on content strategies and implement platforms vastly more complex than ever before.
This session will draw upon case studies from Eli Lilly, Roche, and 3M Lifesciences to outline proven strategies and tactics that can help teams in various content-rich departments move towards omnichannel.
We’ll look at how to successfully implement things like component content (aka modular content that works like LEGO); omnichannel data and analytics integration; and scalable content tagging for personalization and regional compliance.
In this session, attendees will learn:
- How pharma brands can begin their journey towards omnichannel
- How different areas within the pharma enterprise can benefit from shared methodologies and tech — even if they involve very different audiences and processes
- What different pharma teams like Medical Affairs, Medical Information, Commercial, and Systems/Infrastructure can expect from an omnichannel approach.